Connors Investor Services Inc / ABT
Connors Investor Services Inc’s Abbott Laboratories Position
Does Connors Investor Services Inc own Abbott Laboratories (ABT)? Yes — 149.6K shares worth $15M (+1.42% of its 13F portfolio) as of Q1 2026, up from 148.3K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
149.6K
% of Portfolio
+1.42%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 149.6K | $15M | +1.42% |
| Q4 2025 | 148.3K | $19M | +1.60% |
| Q3 2025 | 151.1K | $20M | +1.72% |
| Q2 2025 | 151.6K | $21M | +1.83% |
| Q1 2025 | 155.6K | $21M | +2.05% |
| Q4 2024 | 158.5K | $18M | +1.68% |
| Q3 2024 | 160.5K | $18M | +1.77% |
| Q2 2024 | 165.1K | $17M | +1.79% |
| Q1 2024 | 170.3K | $19M | +2.04% |
| Q4 2023 | 171.8K | $18,907 | +2.12% |
| Q3 2023 | 171.9K | $16,624 | +2.05% |
| Q2 2023 | 172.9K | $18,851 | +2.13% |
| Q1 2023 | 174.6K | $17,676 | +2.08% |
| Q4 2022 | 174.3K | $19M | +2.39% |
| Q3 2022 | 175.9K | $17M | +2.23% |
| Q2 2022 | 173.7K | $19M | +2.38% |
| Q1 2022 | 175.6K | $21M | +2.16% |
| Q4 2021 | 173.2K | $24M | +2.39% |
| Q3 2021 | 168.7K | $20M | +2.11% |
| Q2 2021 | 178.4K | $21M | +2.15% |
| Q4 2020 | 179.5K | $20M | +2.44% |
| Q3 2020 | 205.6K | $22M | +3.13% |
| Q2 2020 | 213.6K | $20M | +2.90% |
| Q1 2020 | 229.0K | $18M | +3.14% |
| Q4 2019 | 225.0K | $20M | +2.48% |
| Q3 2019 | 208.2K | $17M | +2.39% |
| Q2 2019 | 213.2K | $18M | +2.38% |
| Q1 2019 | 213.7K | $17M | +2.33% |
| Q4 2018 | 217.5K | $16M | +2.45% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Connors Investor Services Inc’s full portfolio or all institutional holders of ABT.